Stock data
NRX Pharmaceuticals, Inc. (NRXP)
NRX Pharmaceuticals, Inc. (NRXP) reported revenue of US$1.23M and net income of -US$28.62M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$1.23M | — | -US$16.22M | -US$28.62M | — |
| 2024 | US$0.00M | — | -US$18.50M | -US$25.13M | — |
| 2023 | — | — | -US$27.84M | -US$30.15M | — |
| 2022 | — | — | -US$44.34M | -US$39.75M | — |
| 2021 | — | — | -US$115.80M | -US$93.06M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$1.10M | -US$16.52M | — |
| 2026-03-31 | US$1.07M | -US$1.43M | — |
| 2025-12-31 | US$0.98M | US$0.36M | — |
| 2025-09-30 | US$0.24M | -US$5.89M | — |
| 2025-06-30 | US$0.00M | -US$17.58M | — |
| 2025-03-31 | US$0.00M | -US$5.51M | — |
| 2024-12-31 | — | -US$9.08M | — |
| 2024-09-30 | US$0.00M | -US$1.62M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.